Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters

Similar documents
Clear cell carcinoma arising from abdominal wall endometriosis: a unique case with bladder and lymph node metastasis

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

Survival Analysis and Prognosis for Patients with Serous and Mucinous Borderline Ovarian Tumors: 14-Year Experience from a Tertiary Center in Iran

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

H&E, IHC anti- Cytokeratin

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Study of ascitic fluid cytology in ovarian tumors

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Staging and Treatment Update for Gynecologic Malignancies

A Serous Borderline Tumor of the Fallopian Tube Detected Incidentally

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Article begins on next page

Shina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya

Clinical statistics of gynecologic cancers in Japan

David Nunns on behalf of the Gynae Guidelines Group Date:

Ovarian Tumors: A Study of 2146 Cases at AFIP, Rawalpindi, Pakistan.

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Current Concept in Ovarian Carcinoma: Pathology Perspectives

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact

Interactive Staging Bee

Original contribution

Low-grade serous neoplasia. Robert A. Soslow, MD

Gestione dei tumori borderline iniziali e avanzati nelle donne in età fertile

International Society of Gynecological Pathologists Symposium 2007

Histological pattern of ovarian tumors and their age distribution

IMMATURE TERATOMA: SURGICAL TREATMENT

Gynaecological Pathology Reporting. Peritoneal cytology Tony Williams Birmingham

Stage 3 ovarian cancer survival rate

Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy

Stage 3 ovarian cancer survival rate

INTRODUCTION Ovarian cancer is the leading cause of mortality from gynecologic malignancies in the industrialized countries and is responsible for

Borderline Ovarian Tumours. Andreas Obermair Brisbane

Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases

Histological Pattern of Ovarian Neoplasma

A Survay on Appendiceal Involvement in Ovarian Mucinous Tumors

Malignant transformation in benign cystic teratomas, dermoids of the ovary

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

Endosalpingiosis. Case report

LAPAROSCOPY and OVARIAN CANCER

Endometrial Cancer in Thai Women aged 45 years or Younger

Cytological Features of Cervical Smears in Serous Adenocarcinoma of the Endometrium

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

RESEARCH COMMUNICATION

Chapter 8 Adenocarcinoma

Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy

Immunohistochemistry on Fluid Specimens: Technical Considerations

A new score predicting the survival of patients with spinal cord compression from myeloma

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Prof. Dr. Aydın ÖZSARAN

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

3 cell types in the normal ovary

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Can the Ovaries be preserved in Selected Cases of Endometrial Cancer?

Institute of Pathology First Faculty of Medicine Charles University. Ovary

What is the gynecologist s role in the care of BRCA previvors?

Pre-operative assessment of patients for cytoreduction and HIPEC

Journal of Rawalpindi Medical College (JRMC); 2016;20(4):

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Case Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

RESEARCH ARTICLE. Usanee Chatchotikawong 1, Irene Ruengkhachorn 1 *, Chairat Leelaphatanadit 1, Nisarat Phithakwatchara 2. Abstract.

Interpretation of p53 Immunostains. P53 Mutations are Ubiquitous in High Grade Serous Carcinoma. Diffuse strong positive nuclear staining

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Borderline tumors. Borderline tumors. Serous borderline tumor are NOT benign. Low grade serous carcinoma: pathogenesis. Serous carcinoma: pathogenesis

FREQUENCY AND HISTOLOGICAL SPECTRUM OF MALIGNANT OVARIAN TUMOURS AT KING EDWARD MEDICAL UNIVERSITY, LAHORE

Anshuma Bansal 1 Bhavana Rai

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors

Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines

Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test

Abstract. Introduction. Salah Abobaker Ali

بسم هللا الرحمن الرحيم. Prof soha Talaat

Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder

Screening and prevention of ovarian cancer

Epithelial Ovarian Cancer 8/2/2013. Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer?

Section 1. Biology of gynaecological cancers: our current understanding

Impact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Histopathological Study of Ovarian Lesions

Inherited Ovarian Cancer Diagnosis and Prevention

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

JJCO. Original Article. Banghyun Lee 1, Dong Hoon Suh 2, Kidong Kim 2, Jae Hong No 2, and Yong Beom Kim 2,3, * Abstract

What is endometrial cancer?

ACCME/Disclosures. Risk of Gyne Ca in HBOC. Molecular basis of HBOC. Hereditary Ovarian and Breast Cancer Syndrome

One of the commonest gynecological cancers,especially in white Americans.

Incidence, Histological Types and Age at Presentation of Borderline and Malignant Ovarian Tumors at a Tertiary Institute in Nepal

Janjira Petsuksiri, M.D

The updated incidences and mortalities of major cancers in China, 2011

uterine cancer endometrial cancer

Transcription:

Naz et al. World Journal of Surgical Oncology (2015) 13:315 DOI 10.1186/s12957-015-0732-1 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Role of peritoneal washing in ovarian malignancies: correlation with histopathological parameters Samreen Naz 1, Atif Ali Hashmi 1, Rabia Ali 1, Naveen Faridi 1, Syed Danish Hussian 2, Muhammad Muzzammil Edhi 2 and Mehmood Khan 3* Abstract Background: Peritoneal dissemination of ovarian tumors is a major prognostic parameter in ovarian malignancies. Analysis of peritoneal washing serves as a useful predictor of ovarian surface involvement and peritoneal metastasis even in the absence of clinical omental spread. The aim of the current study is to correlate peritoneal with various histologic features of ovarian cancers in our setup. Methods: A total of 60 cases of ovarian tumors were included in the study that underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy and omental and lymph node sampling during 2009 till 2014 at the Liaquat National Hospital, Karachi. Any free abdominal fluid was aspirated at the time of surgery. In the absence of free fluid, peritoneal washing was done with 50 100 ml of normal saline. Four cytospin preparations were done along with a cell block preparation. Correlation of peritoneal with various histologic parameters was performed. Results: Out of the 60 cases of ovarian tumors involved in the study, 56 were surface epithelial tumors, 2 germ cell tumors, and 2 metastatic carcinomas. The mean tumor size was 9.6 cm. Capsular invasion was seen in 61 % of the cases, and omental metastasis in 51 % of the cases. Serous carcinoma was found to have a significantly higher frequency of positive peritoneal (76.9 %) compared to endometrioid and mucinous carcinomas (44 and 25 %, respectively). A significant positive correlation was seen between positive peritoneal and capsular invasion and omental metastasis with a p value of <0.001. Conclusions: Positive peritoneal washing has been implemented in ovarian cancer guidelines because of its prognostic significance in ovarian tumors. In addition to being an indicator of peritoneal metastasis, positive also correlates with capsular invasion and histologic type in ovarian tumors. Therefore, it should always be used as an adjunctive tool in the surgical management of ovarian tumors. Keywords: Peritoneal washing, Ovarian cancer, Omental metastasis Background Ovarian cancer is a significant cause of morbidity and mortality in women in this part of the world due to lack of any effective screening protocol. According to Karachi cancer registry, ovarian cancer represents the third most common malignancy in Karachi with serous adenocarcinoma being the most common (33.3 %) [1]. Ovarian cancers are usually detected late in the disease course * Correspondence: mehmoodkhan955@yahoo.com 3 Dhaka Medical College, Dhaka, Bangladesh Full list of author information is available at the end of the article when it is significantly enlarged in size to cause abdominal distention and distress. However, despite of being of large sizes, ovarian tumors may still be confined to the ovaries. On the other hand, omental and peritoneal spread of ovarian cancers has a huge impact on prognosis and upstages prognostic morbidity. Analysis of peritoneal washing (PWC) serves as a useful predictor of ovarian surface involvement and peritoneal metastasis in ovarian cancers [2, 3]. It can also detect subclinical peritoneal spread of the disease. While the procedure is routinely done in our institution as part of 2015 Naz et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Naz et al. World Journal of Surgical Oncology (2015) 13:315 Page 2 of 5 the protocol for all surgeries of suspected ovarian malignancies, its usefulness has not been objectively evaluated. The aim of the current study is to correlate peritoneal with various histologic features of ovarian malignancies. Methods The study was approved by the Liaquat National Hospital and Medical College ethical review committee, and written informed consent was obtained from all subjects. A total of 60 cases of borderline and malignant ovarian tumors were included in the study that underwent total abdominal hysterectomy and bilateral salpingooophorectomy (TAH with BSO) along with omental and lymph node samplings at the Liaquat National Hospital, Karachi from January 2009 till December 2014. After opening the abdominal cavity, any free fluid was aspirated. Various areas of peritoneal cavity including paracolic gutters were lavaged with 50 100 ml of normal saline and sent for cytologic examination. Four cytospin preparations were stained with hematoxylin and eosin and Papanicolaou stains after fixation along with a cell block preparation. TAH with BSO was performed afterwards with omental and lymph node samplings. All cases undergoing ovarian surgery with peritoneal cytologic examination, omental and lymph node samplings were consecutively enrolled in the study. Pathologists reporting peritoneal were blinded with the surgical pathology findings. Results of peritoneal were correlated with various histologic features of ovarian tumors including histologic type, grade, tumor size, capsular invasion, and omental metastasis (Figs. 1 and 2), using chi-square test (univariate analysis). A p value of <0.05 was considered as statistically significant. Fig. 1 Positive peritoneal in ovarian serous carcinoma Fig. 2 Capsular invasion in ovarian carcinoma Results The mean age at diagnosis was 49.9 years (±14.8). Out of the 60 cases of ovarian tumors involved in the study, 56 were surface epithelial tumors, 2 germ cell tumors, and 2 metastatic carcinomas. The mean tumor size was 11.2 cm. Capsular invasion was seen in 61 % of tumors and omental metastasis in 51 % of tumors. Table 1 shows the histopathologic features of ovarian tumors involved in the study. Serous tumors were the most frequent histologic subtype followed by mucinous and endometrioid tumors. Serous carcinoma had a significantly higher frequency of positive peritoneal (76.9 %) compared to endometrioid and mucinous carcinomas (44 and 25 %, respectively) as shown in Table 2. A significant positive correlation was seen between positive peritoneal with omental metastasis and capsular invasion with a p value of <0.001 (Tables 3 and 4). Higher grade tumors were more likely to have positive peritoneal than low-grade tumors; however, the p value was not found to be statistically significant (Table 5). Tumors of smaller sizes tend to have a significantly higher incidence of positive peritoneal (Table 6). Discussion Peritoneal washing is a useful indicator of ovarian surface involvement and peritoneal dissemination by ovarian tumors. It may identify subclinical peritoneal spread and thus provide valuable staging and prognostic information [4]. For the same reason, PWC was implemented in ovarian cancer guidelines and is routinely performed in ovarian cancer surgeries. In our study, we report our experience of PWC with emphasis over its correlation with histological parameters, i.e., tumor type, tumor grade, tumor size, capsular invasion, and omental metastasis. Cytology detection rates of abdominal spread in ovarian cancers vary in different studies. Fadare et al. reported

Naz et al. World Journal of Surgical Oncology (2015) 13:315 Page 3 of 5 Table 1 Histopathologic features of ovarian tumors and its correlation with peritoneal Frequency Omental metastasis Capsular invasion Tumor size Frequency(%) Frequency(%) Frequency(%) Mean Serous tumors 27 11.8 Malignant 26 20(76.9) 19(73.1) 22(84.6) 8.6 Borderline 1 0(0) 0(0) 0(0) 15 Mucinous tumors 12 22.6 Malignant 8 2(25) 2(25) 2(25) 24.8 Borderline 4 0(0) 0(0) 1(25) 20.5 Clear cell carcinoma 1 1(100) 1(100) 1(100) 7 Transitional cell carcinoma 2 2(100) 2(100) 1(50) 8 Malignant mixed mullerian tumor 3 2(66.7) 1(33.3) 3(100) 9.3 Endometrioid carcinoma 9 4(44.4) 2(22.2) 3(33.3) 6.5 Metastatic carcinoma 2 1(50) 1(50) 1(50) 3.5 Dysgerminoma 2 1(50) 1(50) 1(50) 11 Poorly differentiated adenocarcinoma 2 2(100) 2(100) 2(100) 7 Total 60 35(58.3) 31(51.6) 37(61.6) 9.65 25 % and Rubin et al. reported 30 % detection rate, while Colgan et al. revealed 50 % detection rate [5 7]. As much as 90 % positive detection rate has also been reported in a study [8]. This can be due to the inclusion of ascitic fluid along with peritoneal washings, as ascitic fluid has a much higher rate of detecting malignant cells. In our observation, serous carcinomas (n = 26.79 %) were most likely and mucinous carcinoma (n = 8, 25 %) were least likely to involve abdominal cavity as represented by positive peritoneal. Forty-four percent of endometrioid carcinoma (n = 9), 100 % of clear cell carcinoma (n = 1), 100 % of transitional cell carcinoma (n = 1), 66 % of malignant mullerian tumors (n = 3), and 50 % of germ cell tumors (n = 2) showed positive. Fadare et al. reported 71.4 % of serous carcinoma (n = 57), 55 % of endometrioid carcinoma (n = 30), 20 % of clear cell carcinoma (n = 19), and 50 % of mucinous carcinoma (n = 13) showing positive peritoneal [5]. Similar study by Rubin et al. analyzed 96 cases of ovarian tumors of which 29 cases showed positive PWC [6]. The histological subtypes included the following: serous, 21 of 66 (32 %); endometrioid, 3 of 11 (27 %); mucinous 0 of 1 (0 %); and clear cell carcinoma, 2 of 3 (66 %). In patients with ovarian serous tumor of low malignant potential and borderline tumors, PWC is a Table 2 Correlation of peritoneal with histological subtype of tumor Peritoneal. p value Positive Negative Frequency % Frequency % Serous carcinoma 20 76.92 6 23.08 0.042 Endometrioid carcinoma 4 44.44 5 55.56 Mucinous carcinoma 2 25.00 6 75.00 Clear cell carcinoma 1 100.00 0 0.00 Transitional cell carcinoma 2 100.00 0 0.00 Malignant mixed mullerian tumor 2 66.67 1 33.33 Borderline serous tumor 0 0.00 1 100.00 Borderline mucinous tumor 0 0.00 4 100.00 Metastatic carcinoma 1 50.00 1 50.00 Dysgerminoma 1 50.00 1 50.00 Poorly differentiated adenocarcinoma 2 100.00 0 0.00 Total 35 58.33 25 41.67

Naz et al. World Journal of Surgical Oncology (2015) 13:315 Page 4 of 5 Table 3 Correlation of peritoneal with capsular invasion Peritoneal Frequency(%) capsular.invasion p value Present Absent Positive 35(58.3) 30(85.7) 5(14.3) <0.001 Negative 25(41.6) 7(28.0) 18(72.0) Total 60 37(61.7) 23(38.3) relatively sensitive indicator for presence of peritoneal implants whether invasive or non-invasive [2]. Positive upstages borderline tumors. Mulvany, in his study, concluded that the clinical value of PWC lies in upstaging 63 % of borderline ovarian tumors [3]. Cheng et al. demonstrated a 44 % positive detection rate of borderline mucinous tumors [9]. However, in our study, there were only five borderline tumor cases (one serous, four mucinous). All showed negative as well as no omental metastasis. Omental metastasis/peritoneal histology are used as a standard to determine the sensitivity and specificity of PWC. In our study, 35 cases showed positive PWC and 31 showed omental metastasis. There were six cases (6/ 35; 17 %) that were positive and histology negative. These included two serous carcinomas, two endometrioid carcinoma, one mucinous carcinoma, and one MMT. Out of 25 negative cases, only two showed omental metastasis (2/25; 8 %), one serous, and one mucinous. Sneige et al., in their study, observed that 11/70 cases (16 %) were positive and biopsy negative [2]. In a study by Zuna and Behrens, 112 ovarian carcinoma cases were analyzed, and only three stage I cases had positive and negative peritoneal histology (two carcinomas and one borderline tumor) [10]. Of these, only patients with borderline tumors were alive at the last follow-up. Other two died of the disease. In one study, late recurrences were reported in patients with low-grade serous tumors having negative staging biopsy, and they concluded that this may be due to sampling error at the site of implant [11]. Hence, stage I disease without omental metastasis but positive may indicate increased risk of tumor recurrence, and this emphasizes the importance of PWC. In our study, the correlation of PWC with omental metastasis was statistically significant. Table 4 Correlation of Peritoneal with Omental Metastasis Peritoneal Frequency(%) omental.metastasis p value Present Absent Positive 35(58.3) 29(82.9) 6(17.1) <0.001 Negative 25(41.6) 2(8.0) 23(92.0) Total 60 31(51.7) 29(48.3) Table 5 Correlation of peritoneal with tumor grade Peritoneal Tumor grade Total p value Low grade High grade Intermediate Positive 1(20 %) 30(66.6 %) 4(40 %) 35(58.3 %) Negative 4(80 %) 15(33.3 %) 6(60 %) 25(41.6 %) 0.058 Total 5(8.3 %) 45(75 %) 10(16.6 %) 60 According to the recent Federation of Gynecology and Obstetrics (FIGO) guidelines, capsular rupture upstages a stage I tumor to stage IC2 and positive to stage IC3 [12]. Hence, determination of capsular integrity is important as this changes cancer stage. In our study, we tried to correlate capsular invasion with PWC. Out of 60 cases, 37 showed capsular invasion but not all showed positive. Of -positive cases, only 5 had capsule intact and out of 25 negative cases, and 7 had capsular rupture. Of 26 serous carcinomas, 22 (84 %) showed capsular invasion while 20 (76.9 %) showed positive. One borderline mucinous tumor had capsular invasion but a negative. All three MMT showed ruptured capsule (invasion) with two showing positive PWC. Only one case (endometrioid carcinoma) showed positive with intact capsule. With or without capsular invasion, the presence of PWC in stage I disease alone is sufficient to upgrade the tumor. We observed a strong correlation between capsular invasion and PWC (p = <0.001). In our study, the mean tumor size was different for different tumor types. It was 11.58 cm for serous tumors, 6.5 cm for endometrioid tumors, and 22 cm for mucinous neoplasms. The largest tumor size was 30 cm of mucinous carcinoma. Positive peritoneal was correlated to tumor size, and we observed that most of the positive cases had tumor size of less than 10 cm (28/35 cases, 84 %) and only one tumor of more than 20 cm showed positive. Interestingly, most (7/8) large tumors (>20 cm) had negative. Of these, only one showed omental metastasis, i.e., histology positive. The rest had intact capsules and no omental metastasis. All large tumors were mucinous. The only large tumor with positive was 30 cm in size with capsular invasion and omental metastasis. We observed that mucinous tumors may acquire large sizes but mostly remain organ confined with negative. Some of the intermediate sized serous tumors Table 6 Correlation of peritoneal with tumor size Peritoneal Tumor size Total p value <10 cm 10 20 cm >20 cm Positive 28(84.8 %) 6(31.5 %) 1(12.5 %) 35(58.3 %) Negative 5(15.1 %) 13(68.4 %) 7(87.5 %) 25(41.6 %) <0.001 Total 33(55 %) 19(31.6 %) 8(13.3 %) 60

Naz et al. World Journal of Surgical Oncology (2015) 13:315 Page 5 of 5 also showed negative. Hence, smaller tumors have a significantly more incidence of positive PWC. Tumor grade also had an impact on abdominal spread of ovarian tumors. We found out that 30 out of the 35 -positive cases had high histological grade, four had intermediate grade, and only one had low grade. Fifteen (33 %) of high-grade tumors showed negative histology. Ozkara reported that PW were significantly more likely to yield malignant cells in higher grade than lower grade tumors [13]. Conclusions In conclusion, positive peritoneal washing is a useful prognostic factor in ovarian tumors. In addition to being an indicator of peritoneal metastasis, positive also correlates with capsular invasion, tumor type, and tumor grade in ovarian tumors. Consent Written informed consent was obtained from the patients for publication of this article and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The approval was obtained from the Liaquat National Hospital and Medical College ethical review committee. 5. Fadare O, Mariappan MR, Wang S, Hileeto D, McAlpine J, Rimm DL. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer. 2004;102(3):150 6. 6. Rubin SC, Dulaney ED, Markman M, Hoskins WJ, Saigo PE, Lewis JL. Peritoneal as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol. 1988;71:851 3. 7. Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B. Peritoneal lavage : an assessment of its value during prophylactic oophorectomy. Gynecol Oncol. 2002;85:397 403. 8. Morton DG, Moore JG, Chang N. The clinical value of peritoneal lavage for cytologic examination. Am J Obstet Gynecol. 1961;81:1115 25. 9. Cheng L, Wolf NG, Rose PG, Rodriguez M, Abdul-Karim FW. Peritoneal washing of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants. Acta Cytol. 1998;42(5):1091 4. 10. Zuna RE, Behrens A. Peritoneal washing in gynecologic cancers: long term follow-up of 355 patients. J Natl Cancer Inst. 1996;88:980 7. 11. Silva EG, Tornos C, Zhuang Z, Merino M, Gershrnson DM. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Intl J Gynecol Pathol. 1998;17(1):1 6. 12. Prat J, for the FIGO committee on gynecologic oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1 5. 13. Ozkara SK. Significance of peritoneal washing cytopathology in ovarian carcinomas and tumors of low malignant potential: a quality control study with literature review. Acta Cytol. 2011;55(1):57 68. Abbreviations FIGO: Federation of Gynecology and Obstetrics; PWC: peritoneal washing. Competing interest The authors declare that they have no competing interests. Authors contributions SN, AAA, and RA were the clinical investigators of this study. AAA, SDH, and MME analyzed the data and wrote the manuscript, NF and MK critically revised it. All authors read and approved the final manuscript. Acknowledgements We acknowledge all members of the histopathology department of Liaquat National Hospital and Medical College, Karachi, Pakistan, for their cooperation. Author details 1 Department of Histopathology, Liaquat National Hospital and Medical College, Karachi, Pakistan. 2 Liaquat National Hospital and Medical College, Karachi, Pakistan. 3 Dhaka Medical College, Dhaka, Bangladesh. Received: 9 May 2015 Accepted: 7 November 2015 References 1. Hasan SH, Zaidi SM. Incidence, trends and morphology of ovarian cancer in Karachi (1995 2002). Asian Pac J Cancer Prev. 2011;12(6):1567 71. 2. Sneige N, Thomison JB, Malpica A, Gong Y, Ensor J, Silva EG. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol. 2012;120(4):238 44. 3. Mulvany N. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol. 1996;40(6):1231 9. 4. Shield P. Peritoneal washing. Cytopathology. 2004;15(3):131 41. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit